DIVIDEND ANNOUNCEMENT: 8.625% Sr Nt 04/30/2026/Harrow Health Inc (NASDAQ:HROWL) on 07/05/2022 declared a dividend of $0.5391 per share

8.625% Sr Nt 04/30/2026/Harrow Health Inc (NASDAQ:HROWL) on 07/05/2022 declared a dividend of $ 0.5391 per share payable on July 31, 2022 to shareholders of record as of July 15, 2022.

8.625% Sr Nt 04/30/2026/Harrow Health Inc (NASDAQ:HROWL) has paid dividends since 2021, has a current dividend yield of 8.9035453796% and has increased its dividends for 0 successive years.

The stock price closed yesterday at $ 24.26 and has a 52 week low/high of $ 22.24 and $ 27.05.

Harrow Health engages in the development, production and sale of medications. Co. owns and operates an ophthalmic pharmaceutical business, ImprimisRx. Through its subsidiaries, Eton Pharmaceuticals, Inc., Co. develops and commercializes drug products; Surface Ophthalmics, Inc., Co. develops and commercializes therapeutics for ocular surface diseases; and Melt Pharmaceuticals, Inc., Co. develops and commercializes proprietary non-intravenous, sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings. Co. also launched a business called Visionology, a membership-based online eye health and medication platform.

For more information on 8.625% Sr Nt 04/30/2026/Harrow Health Inc click here.